Nothing Special   »   [go: up one dir, main page]

DK0990703T3 - Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf - Google Patents

Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf

Info

Publication number
DK0990703T3
DK0990703T3 DK98905674T DK98905674T DK0990703T3 DK 0990703 T3 DK0990703 T3 DK 0990703T3 DK 98905674 T DK98905674 T DK 98905674T DK 98905674 T DK98905674 T DK 98905674T DK 0990703 T3 DK0990703 T3 DK 0990703T3
Authority
DK
Denmark
Prior art keywords
polypeptide
encoding dna
new polypeptide
antibody
dna
Prior art date
Application number
DK98905674T
Other languages
English (en)
Inventor
Hideaki Tada
Mikio Konishi
Daikichi Fukushima
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of DK0990703T3 publication Critical patent/DK0990703T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK98905674T 1997-02-27 1998-02-26 Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf DK0990703T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4314397 1997-02-27
PCT/JP1998/000799 WO1998038304A1 (fr) 1997-02-27 1998-02-26 Nouveau polypeptide, adn le codant et utilisation de ce polypeptide

Publications (1)

Publication Number Publication Date
DK0990703T3 true DK0990703T3 (da) 2008-09-29

Family

ID=12655623

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98905674T DK0990703T3 (da) 1997-02-27 1998-02-26 Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf

Country Status (9)

Country Link
US (3) US7396908B2 (da)
EP (1) EP0990703B1 (da)
KR (1) KR20000075749A (da)
AT (1) ATE397662T1 (da)
DE (1) DE69839582D1 (da)
DK (1) DK0990703T3 (da)
ES (1) ES2307313T3 (da)
PT (1) PT990703E (da)
WO (1) WO1998038304A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9376498A (en) * 1997-09-05 1999-03-22 University Of Washington Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
CA2301173C (en) * 1997-09-12 2015-04-14 Biogen, Inc. Cysteine rich receptors-train
JP2002508934A (ja) * 1997-12-29 2002-03-26 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Tnfレセプターに対して相同性を有する、新規な核酸およびポリペプチド
EP1053351A4 (en) * 1998-01-27 2002-09-25 Millennium Pharm Inc NOVEL TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMIL MOLECULES AND USES THEREOF
WO2000049149A1 (fr) * 1999-02-19 2000-08-24 Toshio Kitamura Nouvelles proteines du type recepteurs des tnf
US6951738B2 (en) 1999-07-16 2005-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR13 and TR14
WO2001005834A1 (en) * 1999-07-16 2001-01-25 Human Genome Sciences, Inc. Human tumor necrosis factor receptors tr13 and tr14
US20020068696A1 (en) * 2000-02-11 2002-06-06 Clive Wood Trade molecules and uses related thereto
JP5060293B2 (ja) 2004-08-03 2012-10-31 バイオジェン・アイデック・エムエイ・インコーポレイテッド 神経機能におけるtaj
WO2014013037A1 (en) * 2012-07-18 2014-01-23 Apogenix Gmbh Shortened cd95-fc variants
HUE033422T2 (en) 2012-10-24 2017-11-28 Basf Se A process for the preparation of isocyanates by phosgenation of amines in a liquid phase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9214857D0 (en) 1992-07-13 1992-08-26 Medical Res Council Human nucleic acid fragments and their use
CA2301173C (en) 1997-09-12 2015-04-14 Biogen, Inc. Cysteine rich receptors-train

Also Published As

Publication number Publication date
US7705140B2 (en) 2010-04-27
EP0990703A1 (en) 2000-04-05
ES2307313T3 (es) 2008-11-16
US7396908B2 (en) 2008-07-08
US8008451B2 (en) 2011-08-30
EP0990703B1 (en) 2008-06-04
US20080175843A1 (en) 2008-07-24
KR20000075749A (ko) 2000-12-26
ATE397662T1 (de) 2008-06-15
WO1998038304A1 (fr) 1998-09-03
PT990703E (pt) 2008-08-27
US20100298546A1 (en) 2010-11-25
DE69839582D1 (de) 2008-07-17
EP0990703A4 (en) 2001-09-12
US20040142423A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
HU9600692D0 (en) Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
NL300272I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
IL143670A0 (en) Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
ATE177758T1 (de) Synthetische peptide, antikörper dagegen und ihre verwendung
DE69433690D1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
ATE295423T1 (de) Phosphodiesterase 8
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
NO910982L (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
NO972063L (no) Isolert BMP-reseptorkinaseprotein, DNA-sekvens, rekombinant ekspresjonsvektor samt vertscelle
NO922421L (no) Collagenbindende protein, samt fremstilling derav
ITRM920506A1 (it) Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
BR9911609A (pt) Proteìnas e genes de moraxella catarrhalis, antìgenos, anticorpos e usos
NO974713L (no) Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
DK130290A (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner
GB9604518D0 (en) Novel compounds
SE9604439D0 (sv) New receptor
NO895154D0 (no) Fremgangsmaate ved fremstilling av et protein eller polypeptid, en dna-sekvens som koder for polypeptidet, en mikroorganisme som inneholder dna-sekvensen samt polypeptidet ogdets anvendelse som et farmasoeytisk preparat.
NO940797L (no) Reseptorderivater som har bindingseter for human-rhinovirus
BR0016740A (pt) Antìgenos de esporozoìto de cryptosporidium
DK0386733T3 (da) cDNA, som koder for placentaprotein 9 (PP9), dets isolering og anvendelse
MX9701904A (es) Proteinas de enlace de pka novedosas y usos de las mismas.
NO920500D0 (no) Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav